BR112015001352A2 - POLYPEPTIDE, CHIMERIC PROTEIN, POLYNUCLEOTIDE, VECTOR, CELL CULTURE, COMPOSITION, AND USES OF A CHIMERIC PROTEIN AND COMPOSITION - Google Patents

POLYPEPTIDE, CHIMERIC PROTEIN, POLYNUCLEOTIDE, VECTOR, CELL CULTURE, COMPOSITION, AND USES OF A CHIMERIC PROTEIN AND COMPOSITION

Info

Publication number
BR112015001352A2
BR112015001352A2 BR112015001352A BR112015001352A BR112015001352A2 BR 112015001352 A2 BR112015001352 A2 BR 112015001352A2 BR 112015001352 A BR112015001352 A BR 112015001352A BR 112015001352 A BR112015001352 A BR 112015001352A BR 112015001352 A2 BR112015001352 A2 BR 112015001352A2
Authority
BR
Brazil
Prior art keywords
composition
chimeric protein
polypeptide
polynucleotide
vector
Prior art date
Application number
BR112015001352A
Other languages
Portuguese (pt)
Inventor
Misseri Yolande
Bridonneau Philippe
Goubier Anne
Original Assignee
Genticel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP12305898.4A external-priority patent/EP2689786A1/en
Application filed by Genticel filed Critical Genticel
Publication of BR112015001352A2 publication Critical patent/BR112015001352A2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

POLIPEPTÍDEO, PROTEÍNA QUIMÉRICA, POLINUCLEOTÍDEO, VETOR, CULTURA DE CÉLULA, COMPOSIÇÃO, E, USOS DE UMA PROTEÍNA QUIMÉRICA E DE UMA COMPOSIÇÃO. A invenção refere-se a uma proteína quimérica compreendendo ou consistindo em, desde a terminação-N até a terminação-C, (a) uma parte N-terminal de uma proteína CyaA de Bordetella (b) um polipeptídeo heterólogo compreendendo antígenos que se originam de HPVs diferentes, e (c) uma parte C-terminal de uma proteína CyaA de Bordetella. A invenção também se refere a um polinucleotídeo que codifica esta proteína quimérica. Uma composição compreendendo pelo menos uma(s) proteína(s) quimérica(s) da invenção e os usos profiláticos e/ou terapêuticos de dita composição também são parte da invenção.POLYPEPTIDE, CHIMERIC PROTEIN, POLYNUCLEOTIDE, VECTOR, CELL CULTURE, COMPOSITION, AND, USES OF A CHIMERIC PROTEIN AND COMPOSITION. The invention relates to a chimeric protein comprising or consisting of, from the N-terminus to the C-terminus, (a) an N-terminal part of a Bordetella CyaA protein (b) a heterologous polypeptide comprising antigens that originate from different HPVs, and (c) a C-terminal part of a Bordetella CyaA protein. The invention also relates to a polynucleotide encoding this chimeric protein. A composition comprising at least one chimeric protein(s) of the invention and the prophylactic and/or therapeutic uses of said composition are also part of the invention.

BR112015001352A 2012-07-23 2013-07-23 POLYPEPTIDE, CHIMERIC PROTEIN, POLYNUCLEOTIDE, VECTOR, CELL CULTURE, COMPOSITION, AND USES OF A CHIMERIC PROTEIN AND COMPOSITION BR112015001352A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12305898.4A EP2689786A1 (en) 2012-07-23 2012-07-23 HPV/CYAA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders
EP2014016312 2014-01-30

Publications (1)

Publication Number Publication Date
BR112015001352A2 true BR112015001352A2 (en) 2022-06-28

Family

ID=83355827

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015001352A BR112015001352A2 (en) 2012-07-23 2013-07-23 POLYPEPTIDE, CHIMERIC PROTEIN, POLYNUCLEOTIDE, VECTOR, CELL CULTURE, COMPOSITION, AND USES OF A CHIMERIC PROTEIN AND COMPOSITION

Country Status (1)

Country Link
BR (1) BR112015001352A2 (en)

Similar Documents

Publication Publication Date Title
PH12020550205A1 (en) IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
SA520412669B1 (en) Manufacture of Recombinant Clostridium Botulinum Neurotoxins
PH12018501280A1 (en) Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
MX2017006866A (en) Fusion partners for peptide production.
MX2016008782A (en) Fc-region variants with improved protein a-binding.
GEP20217326B (en) Constructs having a sirp-alpha domain or variant thereof
MX2019008803A (en) Antibodies to plasminogen activator inhibitor-1 (pai-1) and uses thereof.
TN2014000360A1 (en) Cx3cr1-binding polypeptides
MX2021001460A (en) Methods and compositions for secretion of heterologous polypeptides.
MX2021008318A (en) Novel specific-binding polypeptides and uses thereof.
MX359315B (en) Dna vaccine for use in pancreatic cancer patients.
BR112017020308A2 (en) udp-glycosyltransferases
EP4011906A3 (en) Lactase enzymes with improved properties
BR112018001121A2 (en) recombinant orf virus vector (orfv), cell, composition, use of an orfv recombinant vector, and nucleic acid molecule
BR112015003724A2 (en) isolated polypeptide, composition, use of a composition, isolated polynucleotide, nucleic acid construct or expression vector, recombinant host cell, and methods of producing a polypeptide and producing a protein.
MY173686A (en) Fc gamma receptor iib variants
BR112017001463A2 (en) improved host cell to produce proteins
BR112015001350A2 (en) polynucleotide, chimeric polynucleotide, polynucleotide use, vector, cell culture, cyaa-derived protein, chimeric protein, composition, and method for producing a chimeric protein
WO2014170460A3 (en) Method for the production of collagen proteins derived from marine sponges and an organism able to produce said proteins
AU2018277310A1 (en) Aggrecan binding immunoglobulins
MX2017003729A (en) Statherin peptides.
TR201900695T4 (en) HPV / CYAA-BASED CHEMICAL PROTEINS AND THEIR USE IN INDUCING IMMUNE RESPONSE AGAINST HPV INFECTION AND HPV-INDUCED DISASTER.
MX2018003445A (en) Expression of fc-containing proteins.
BR112015001352A2 (en) POLYPEPTIDE, CHIMERIC PROTEIN, POLYNUCLEOTIDE, VECTOR, CELL CULTURE, COMPOSITION, AND USES OF A CHIMERIC PROTEIN AND COMPOSITION
MX2016017094A (en) Clostridium difficile immunogenic composition.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2687 DE 05-07-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.